Borislav D Dimitrov

Summary

Publications

  1. pmc Cyclic patterns of incidence rate for skin malignant melanoma: association with heliogeophysical activity
    Borislav D Dimitrov
    BORDANI, Alzano Lombardo BG 24022, Italy
    J Zhejiang Univ Sci B 9:489-95. 2008
  2. pmc Brain metastases of melanoma--mechanisms of attack on their defence system by engineered stem cells in the microenvironment
    Borislav D Dimitrov
    BORDANI, Alzano Lombardo, Bergamo 24022, Italy
    J Zhejiang Univ Sci B 8:609-11. 2007
  3. doi request reprint Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics
    Penka A Atanassova
    Department of Neurology, Medical University, Plovdiv, Bulgaria
    Cerebrovasc Dis 25:225-33. 2008
  4. ncbi request reprint Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patients
    Penka A Atanassova
    Department of Neurology, Medical University 15A, V Aprilov Boulevard, Plovdiv 4000, Bulgaria
    Arq Neuropsiquiatr 65:24-31. 2007
  5. ncbi request reprint Long-term outcome of renal transplantation from older donors
    Giuseppe Remuzzi
    Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy
    N Engl J Med 354:343-52. 2006
  6. ncbi request reprint Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results
    Giuseppe Remuzzi
    Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy
    J Am Soc Nephrol 15:3117-25. 2004
  7. ncbi request reprint Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes
    Aneliya Parvanova
    Mario Negri Institute for Pharmacological Research, Negri Bergamo Laboratories, Via Gavazzeni 11, 24125 Bergamo, Italy
    J Clin Endocrinol Metab 89:4371-6. 2004
  8. ncbi request reprint Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
    Giuseppe Remuzzi
    Clinical Research Centre for Rare Diseases, Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy
    Lancet 364:503-12. 2004
  9. ncbi request reprint In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial
    Norberto Perico
    Department of Medicine and Transplantation, Azienda Ospedaliera, Ospedali Riuniti di Bergamo Mario Negri Institute for Pharmacological Research, Bergamo, Italy
    Kidney Int 65:1084-90. 2004
  10. ncbi request reprint Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model
    Borislav D Dimitrov
    Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy
    Nephron Clin Pract 95:c47-59. 2003

Collaborators

  • P A Atanassova
  • Plamen G Tzvetanov
  • G Remuzzi
  • Dick de Zeeuw
  • M Salvadori
  • S Sandrini
  • Aneliya Parvanova
  • Piero Ruggenenti
  • Norberto Perico
  • Ilian Iliev
  • Esther N Oliva
  • Giuseppe Segoloni
  • Flavio Gaspari
  • Maria Ganeva
  • Eliana Gotti
  • Monica Vedovato
  • Dario Cattaneo
  • Donato Donati
  • Marco Filipponi
  • Umberto Valente
  • Roberto Trevisan
  • Antonio Tiengo
  • Federica Arnoldi
  • Jelka Zaletel
  • Francesco Nobile
  • Arianna D'Angelo
  • Bruno Martino
  • Annalisa Perna

Detail Information

Publications13

  1. pmc Cyclic patterns of incidence rate for skin malignant melanoma: association with heliogeophysical activity
    Borislav D Dimitrov
    BORDANI, Alzano Lombardo BG 24022, Italy
    J Zhejiang Univ Sci B 9:489-95. 2008
    ..e., out of phase. We summarized and explored more deeply these cyclic variations and discussed their possible associations with heliogeophysical activity (HGA) components exhibiting similar cyclicity...
  2. pmc Brain metastases of melanoma--mechanisms of attack on their defence system by engineered stem cells in the microenvironment
    Borislav D Dimitrov
    BORDANI, Alzano Lombardo, Bergamo 24022, Italy
    J Zhejiang Univ Sci B 8:609-11. 2007
    ....
  3. doi request reprint Major vascular events after transient ischaemic attack and minor ischaemic stroke: post hoc modelling of incidence dynamics
    Penka A Atanassova
    Department of Neurology, Medical University, Plovdiv, Bulgaria
    Cerebrovasc Dis 25:225-33. 2008
    ..Estimates of relative risk and cumulative long-term occurrence of MVE may provide better information and contribute to the optimization of treatment decisions...
  4. ncbi request reprint Modelling of increased homocysteine in ischaemic stroke: post-hoc cross-sectional matched case-control analysis in young patients
    Penka A Atanassova
    Department of Neurology, Medical University 15A, V Aprilov Boulevard, Plovdiv 4000, Bulgaria
    Arq Neuropsiquiatr 65:24-31. 2007
    ..We evaluated relationships between THCY and prevalence of other potential risk factors in 41 patients vs. 41 healthy controls...
  5. ncbi request reprint Long-term outcome of renal transplantation from older donors
    Giuseppe Remuzzi
    Azienda Ospedaliera, Ospedali Riuniti di Bergamo, Bergamo, Italy
    N Engl J Med 354:343-52. 2006
    ..We sought to determine whether selecting older kidneys according to their histologic characteristics before implantation would positively influence long-term outcome...
  6. ncbi request reprint Continuum of renoprotection with losartan at all stages of type 2 diabetic nephropathy: a post hoc analysis of the RENAAL trial results
    Giuseppe Remuzzi
    Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Via Gavazzeni 11, 24125 Bergamo, Italy
    J Am Soc Nephrol 15:3117-25. 2004
    ..Angiotensin II antagonism is a suitable and well-tolerated treatment for individuals with type 2 diabetes even with GFR levels approaching renal replacement therapy...
  7. ncbi request reprint Insulin resistance and proliferative retinopathy: a cross-sectional, case-control study in 115 patients with type 2 diabetes
    Aneliya Parvanova
    Mario Negri Institute for Pharmacological Research, Negri Bergamo Laboratories, Via Gavazzeni 11, 24125 Bergamo, Italy
    J Clin Endocrinol Metab 89:4371-6. 2004
    ..Longitudinal studies are needed to evaluate the role of IR in the pathogenesis of proliferative retinopathy...
  8. ncbi request reprint Mycophenolate mofetil versus azathioprine for prevention of acute rejection in renal transplantation (MYSS): a randomised trial
    Giuseppe Remuzzi
    Clinical Research Centre for Rare Diseases, Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy
    Lancet 364:503-12. 2004
    ..We aimed to compare the antirejection activity of these two drugs with a new formulation of ciclosporin...
  9. ncbi request reprint In renal transplantation blood cyclosporine levels soon after surgery act as a major determinant of rejection: insights from the MY.S.S. trial
    Norberto Perico
    Department of Medicine and Transplantation, Azienda Ospedaliera, Ospedali Riuniti di Bergamo Mario Negri Institute for Pharmacological Research, Bergamo, Italy
    Kidney Int 65:1084-90. 2004
    ..Here, we aimed to assess this possibility in a large cohort of de novo kidney transplant recipients participating in an ongoing clinical trial, the Mycophenolate Steroid-Sparing (MY.S.S.) Trial...
  10. ncbi request reprint Chronic nephropathies: individual risk for progression to end-stage renal failure as predicted by an integrated probabilistic model
    Borislav D Dimitrov
    Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica, Bergamo, Italy
    Nephron Clin Pract 95:c47-59. 2003
    ..To predict risk of end-stage renal disease (ESRD) in individual patients with chronic nephropathy...
  11. ncbi request reprint Predicting end-stage renal disease: Bayesian perspective of information transfer in the clinical decision-making process at the individual level
    Borislav D Dimitrov
    Department of Renal Medicine, Clinical Research Centre for Rare Diseases Aldo e Cele Dacco, Mario Negri Institute for Pharmacological Research, Villa Camozzi, Ranica BG, Italy
    Kidney Int 63:1924-33. 2003
    ..Predicting outcomes such as end-stage renal disease (ESRD) by integration and better utilization at individual level of epidemiologic data may facilitate clinical decision-making processes...
  12. ncbi request reprint Hyperhomocysteinemia and increased risk of retinopathy: a cross-sectional, case-control study in patients with type 2 diabetes
    Aneliya Parvanova
    Clinical Research Center for Rare Diseases Aldo e Cele Daccò, Mario Negri Institute for Pharmacological Research, Bergamo, Italy
    Diabetes Care 25:2361. 2002
  13. ncbi request reprint More concern about transfusion requirement when evaluating quality of life in anemic patients
    Esther N Oliva
    J Clin Oncol 20:3182-3; author reply 3183-4. 2002